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Abstract 
Background: Population attributable fractions (PAFs) are frequently used to quantify the proportion of Type 2 dia-
betes cases due to single risk factors, an approach which may result in an overestimation of their individual contri-
butions. This study aimed to examine Type 2 diabetes incidence associated with multiple risk factor combinations, 
including the metabolic syndrome, behavioural factors, and specifically, depression and anxiety.
Methods: Using data from the population-based HUNT cohort, we examined incident diabetes in 36,161 Norwegian 
adults from 1995 to 2008. PAFs were calculated using Miettinen’s case-based formula, using relative risks estimated 
from multivariate regression models.
Results: Overall, the studied risk factors accounted for 50.5% of new diabetes cases (78.2% in men and 47.0% in 
women). Individuals exposed to both behavioural and metabolic factors were at highest risk of diabetes onset 
(PAF = 22.9%). Baseline anxiety and depression contributed a further 13.6% of new cases to this combination. Men 
appeared to be particularly vulnerable to the interaction between metabolic, behavioural and psychological risk 
factors.
Conclusion: This study highlights the importance of risk factor clustering in diabetes onset, and is the first that we 
know of to quantify the excess fraction of incident diabetes associated with psychological risk factor interactions.
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Background
Over 400 million adults worldwide are currently diag-
nosed with Type 2 diabetes, a prevalence that has more 
than doubled over the past three decades and continues 
to rise [1]. To address what is increasingly referred to 
as a global health crisis, many countries are investing 
in programs aimed at reducing the main modifiable risk 
factors of diabetes: obesity, smoking, unhealthy eat-
ing, and physical inactivity. Alongside these traditional 
risk factors, psychological factors are increasingly 
noted as being important to the pathogenesis of dia-
betes [2]. It has long been suggested that the risk of 
Type 2 diabetes is elevated by depression [3], and a 
growing evidence base has established depression as 
an independent risk factor for diabetes onset. Depres-
sion may trigger diabetogenic processes by influencing 
both behavioural and biological pathways (Fig. 1). This 
body of research extends to the effects of depression 
on obesity [4], physical activity [5], insulin resistance 
[6], and glycemic control [7]. Anxiety disorders repre-
sent a less frequently studied risk factor for diabetes 
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the dysregulation of metabolic and inflammatory pro-
cesses as depression (e.g., through HPA-axis activation 
[8] or cytokine-mediated autoimmune responses [9]) 
(Fig. 1). While major depression and generalized anxi-
ety disorder share four common symptoms (according 
to DSM-V criteria) [10], they are also characterized by 
heterogenous symptoms that may act in direct oppo-
sition to one other (e.g., insomnia versus hypersom-
nia, restlessness versus motor retardation). Anxiety is 
unique in that some of its symptoms may even confer 
protective benefits (e.g., anxiety has been associated 
with low blood pressure in a large community-based 
sample of individuals (N = 60,700) [11]). Notably, anxi-
ety disorders and depression are seen to occur together 
in over 50% of primary care cases [12]. Modalities for 
the treatment of patients with depression comorbid 
with diabetes include psychosocial interventions (e.g., 
cognitive-behaviour therapy), pharmacological inter-
ventions (e.g., selective-serotonin reuptake inhibitors), 
and collaborative care models (e.g., stepped care or 
algorithm-based approaches), all of which have been 
demonstrated to achieve improvements over usual-care 
for diabetes on key outcomes [13, 14].
In 2008, Cosgrove et  al. estimated the attributable 
risk of developing Type 2 diabetes following an epi-
sode of depression to be 20%, and the total population 
fraction of diabetes cases attributable to depression at 
4% [15]. Population attributable fractions (PAFs) are 
a common and useful method of quantifying the bur-
den of disease attributable to a specific risk factor, and 
take into account both the strength of the association 
between the risk factor and disease and the wider pop-
ulation health impact of that risk factor [16]. PAFs have 
been used to describe the proportion of Type 2 diabetes 
cases due to physical inactivity [16], obesity [17], sugar 
intake [18], metabolic factors [19], and specific genetic 
variants [20]. For example, a recent study concluded 
that the proportion of diabetes cases attributable to 
sugar-sweetened beverages was 8.7% (3.9% to 12.9%) 
in the United States [18]. The authors concluded that, 
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Fig. 1 Pathological mechanisms linking depression and anxiety to diabetes outcomes through lifestyle and biological risk factors
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expected to cause approximately 2 million excess diabe-
tes cases over 10 years in the US [18].
Although researchers are often compelled to quan-
tify the PAFs for individual factors, the reality is that 
risk factors often cluster and may interact to amplify 
the risk associated with any one factor. Various studies 
have documented that individuals with certain combi-
nations of risk factors are at higher risk of cardiovas-
cular disease [21–23], and that screening can be more 
efficient if multiple risk factors are considered [24]. As 
the bulk of chronic diseases and subsequent mortality 
are attributable to risk factor combinations, the calcu-
lation of the PAF for any risk factor individually may 
greatly overestimate the risk associated with that fac-
tor [25]. A relatively sparse body of research has used 
a multiple risk factor approach to quantify the burden 
of diabetes onset [26], and no studies to date appear to 
have included an examination of depression and anxi-
ety. The purpose of this study was to determine the PAF 
for multiple risk factor combinations for Type 2 diabe-
tes, including symptoms of depression and anxiety, in a 
population-based sample of Norwegian adults.
Methods
Data source and participants
This study used cohort data from The Norwegian 
Nord-Trøndelag Health Study (HUNT Study), a 
population-based survey conducted over 3 waves: 
HUNT 1 (1984–86), HUNT 2 (1995–97) and HUNT 3 
(2006–08). The HUNT study was initially established 
to address four major health outcomes (i.e., diabe-
tes, hypertension, tuberculosis, and quality of life). 
The scope has broadened over time to include preva-
lence and incidence of disease, health determinants, 
and a state-of-the-art biobank [27]. Every citizen of 
Nord-Trøndelag county aged 20+ years was invited to 
participate. A total of 77,212 (89.4%) of those invited 
participated in the first wave of the survey, followed 
by 65,237 (69.5%) in HUNT 2, and 50,807 in HUNT 3 
(54.1%) [27]. Further details of the HUNT cohort pro-
file and methodology are well-described elsewhere [27].
The longitudinal HUNT 2–3 cohort consisted of 
37,071 individuals who participated in the two most 
recent waves of the study. Our study sample consisted 
of participants in this cohort who did not have a con-
firmed diagnosis of diabetes (Type 1, Type 2, or LADA) 
at baseline in 1995–97 (HUNT 2), totaling 36,161 indi-
viduals. All participants provided written informed 
consent, and study protocols were approved by Nor-
way’s Regional Committee for Medical and Health 
Research Ethics (2014/2160/REK West).
Primary outcome: Type 2 diabetes onset
Our primary outcome was new Type 2 diabetes cases 
occurring between 1995 and 2008. Diabetes incidence 
was assessed in 2006–08 (HUNT 3), and confirmed 
based on results of three repeated laboratory tests 
(fasting plasma glucose, oral glucose tolerance, and 
serum HbA1c levels). All individuals were additionally 
confirmed to be anti-glutamic acid decarboxylase and 
anti-insulinoma-associated negative (to exclude LADA 
cases).
Risk factors for Type 2 diabetes onset
Our primary study risk factors were divided into three 
categories: metabolic, behavioural, and psychological. 
We classified the metabolic syndrome according to the 
International Diabetes Federation consensus worldwide 
definition [28]. Central obesity was indicated if waist 
circumference exceeded 94  cm for men or 79  cm for 
women. Low high-density lipoprotein (HDL) cholesterol 
was indicated at levels below 40  mg/dL (1.03  mmol/L) 
in men and 50 mg/dL (1.29 mmol/L) in women. Hyper-
tension was indicated at a systolic blood pressure 
> 130  mmHg or diastolic > 85  mmHg. Random plasma 
glucose ≥ 200 mg/dL (11.1 mmol/L) was used to indicate 
hyperglycemia (as fasting glucose measurements were 
not available) [29]. The metabolic syndrome was defined 
as having central obesity plus any two of the latter four 
factors [28].
Two major behavioural factors in the onset of diabetes 
were included: physical inactivity and smoking. Individu-
als were classified as physically inactive if they fell below 
the cut-off of 150  min of moderate or 60  min of vigor-
ous physical activity per week (corresponding to World 
Health Organization guidelines [30]). Smoking was 
included if either former or current daily smoking were 
reported, as both have known associations with diabe-
tes onset [31], and included as total number of packyears 
smoked (calculations based on 20 cigarettes/pack). The 
presence of either of these two factors were considered 
an indicator of behavioural risk in calculations of popula-
tion attributable fractions.
Symptoms of depression and anxiety were measured 
using a 7-item mental health index (CONOR-MHI). 
These items consisted of widely validated items from the 
General Health Questionnaire and the Hopkins Symptom 
Checklist (HSCL). The index was evaluated against both 
the HSCL-10 and the Hospital Anxiety and Depression 
Scale (HADS) within both the HUNT Study and Oslo 
Health Study cohorts, and found to have strong accu-
racy when tested against each of these scales as a gold 
standard (AUC = 0.902 and AUC = 0.909, respectively) 
[32]. Individuals were classified as having depression or 
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anxiety if their mean scores on depression or anxiety 
items fell above the recommended cut-off of 2.15 [32].
Additional covariates
Age was considered as a continuous covariate and speci-
fied using restricted cubic splines in multivariate regres-
sion analyses, to account for the non-linear relationship 
between age and diabetes onset (as per Harrell’s method 
[33]). Education was classified as having completed any 
post-secondary versus no higher education. The pres-
ence of any additional chronic conditions (i.e., asthma, 
angina pectoris, any type of cancer or thyroid disease) 
was included dichotomously.
Statistical analysis
Relative risks were estimated using univariate and mul-
tivariate regression models. Analyses were performed 
using generalized linear mixed models for binary data 
in STATA 14.0. All models controlled for age and were 
stratified by sex. Adjusted models were constructed using 
all covariates and all possible two-way interaction terms. 
Models were built using backwards selection, and all 
variables significant at the α = 0.10 level were included in 
the final models. Regressions were conducted following 
imputation of missing covariate values, under the mul-
tiple imputation by chained equations (MICE) method 
[34]. This technique created 30 imputed datasets, from 
which reported estimates were computed. The amount of 
data missing was low (1%–7%) on almost all covariates.
The population attributable fraction (PAF) was then 
calculated for strata in which the relative risk was greater 
than 1.0 and significant at the α = 0.05 level. PAFs were 
calculated using Miettinen’s case-based formula
where  RRi equals the relative risk associated with the 
strata in question and  CFi denotes the case fraction 
(CF = number of exposed cases/total number of cases) 
[35]. This approach was selected over the original for-
mula for calculating attributable fractions popularized 
by Levin [36], as it produces internally valid estimates in 
the presence of confounding and when adjusted relative 
risks must be used. A sensitivity analysis comparing the 
two approaches was also conducted (see Additional file 3: 
Table S3).
Results
Of the 36,161 participants, 55% were female and the 
majority were between 20 and 61 years of age (Table 1). 
Men and women differed to some extent with respect 
to all baseline diabetes risk factors, with the most pro-
nounced differences corresponding to higher rates of 
central obesity and physical inactivity in women, and 
PARi = (RRi − 1)/RRi × CFi,
higher rates of hypertension and elevated triglycerides 
in men (Table 1). Overall, symptoms of either depression 
or anxiety were present in 8.8% of individuals at baseline. 
A total of 1324 incident cases of diabetes were reported 
during the study period, 655 cases occurring in women 
and 669 cases in men.
In univariate analysis, the relative risk of diabetes inci-
dence increased more than fivefold in the presence of 
the metabolic syndrome (Table  2). Smoking was asso-
ciated with diabetes incidence in men only (RR = 1.63 
[95% CI 1.33, 2.00]), as were depression and comor-
bid depression-anxiety (RR = 1.65 [95% CI 1.24, 2.20], 
and RR = 2.07 [95% CI 1.41, 3.05], respectively). Physi-
cal inactivity was associated with a 1.5-fold increase in 
diabetes risk for both sexes. Symptoms of anxiety alone 
were not associated with elevated diabetes risk in either 
sex. A dose–response increase in diabetes risk was also 
observed, with respect to the number of metabolic, 
behavioural and mental health risk factors present. This 
ranged from two factors (RR = 2.62 [95% CI 1.97, 3.50]) 
to ≥ 4 factors (RR = 11.89 [95% CI 9.22, 15.34]).
The final multivariate model included education and 
age as covariates, and excluded the presence of other 
chronic conditions. The presence of the metabolic syn-
drome alone contributed 8.4% of cases (Fig. 2; Table 3). 
Behavioural factors alone were not associated with any 
new cases; however, behavioural factors in conjunction 
with the metabolic syndrome were associated with 22.9% 
of cases. In conjunction with concurrent depression-anx-
iety, behavioural factors contributed an additional 1.4% 
of cases. The strata associated with the most incident 
diabetes cases was therefore the metabolic syndrome 
in conjunction with behavioural factors (PAF = 22.9%). 
The presence of either depression, anxiety or concur-
rent depression-anxiety conferred an additional 13.6% of 
cases to this risk factor combination (PAFs = 2.5%, 4.9%, 
and 6.2%, respectively). No diabetes cases in the overall 
sample were attributable to the presence of psychological 
risk factors alone (Table 3). 
The highest adjusted relative risk of incident diabe-
tes was observed in individuals with all four risk factors 
(RR = 7.47 [95% CI 5.79, 9.64]), but this combination 
occurred in less than 2% of exposed individuals, result-
ing in a PAF of 6.2% overall. In men experiencing all four 
risk factors, the relative risk of diabetes was 12.57 (95% 
CI 8.67, 16.22) and the PAF was 8.4% (Additional file 1: 
Table  S1; Fig.  2). These were substantially higher than 
the results observed in women (RR = 4.49 [95% CI 3.06, 
6.60], PAF = 4.0%) (Additional file 2: Table S2; Fig. 3).
As illustrated in Fig.  3, the pattern of risk for diabe-
tes incidence was more pronounced in men than in 
women. Behavioural factors alone conferred a substan-
tial proportion of cases in men only (PAF = 8.9%). This 
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proportion was even higher in the presence of depres-
sion (PAF = 10.9%). Conversely, a larger proportion of 
cases were attributable to the metabolic syndrome alone 
in women than men (PAFs = 9.8% and 6.7%, respectively). 
The total PAF for all risk factor combinations was 50.5% 
(women = 47.0%, men = 78.2%). In all instances, the 
Miettinen PAF estimates were more conservative than 
those calculated using Levin’s formula (Additional file 3: 
Table S3).
Discussion
This study examined the population attributable fraction 
of Type 2 diabetes incidence associated with the meta-
bolic syndrome, behavioural factors, and depression and 
anxiety in a cohort of Norwegian adults. Overall, these 
factors accounted for 50.5% of new diabetes cases, a 
proportion that was higher in men (78.2%) than women 
(47.0%). Symptoms of depression and anxiety contrib-
uted to diabetes incidence, but they did so only in con-
junction with metabolic and behavioural risk factors. 
The group at highest risk for diabetes incidence was indi-
viduals exposed to both behavioural and metabolic fac-
tors (PAF = 22.9%); anxiety and depression contributed 
a further 13.6% of new cases to this combination. Men 
appeared to be particularly vulnerable to the interaction 
between metabolic, behavioural and psychological risk 
factors.
In the overall cohort, the PAFs associated with depres-
sion or anxiety alone were negligible, despite our multi-
variate analysis reflecting a relative risk of diabetes onset 
of roughly 1.40 for depression, which is in line with previ-
ous research [37]. However, as mentioned above, depres-
sion and anxiety in combination with behavioural and/
or metabolic factors contributed to a substantial pro-
portion of excess cases—a total of 19.2% across strata. 
For all strata containing depressive symptoms the PAF 
was 12.5%, considerably exceeding the 4.0% for depres-
sion alone estimated by Cosgrove et  al. based on a risk 
estimate of 1.25 [15]. It is worth noting that the latter 
PAF was calculated using Levin’s formula and examined 
Table 1 Baseline characteristics of the HUNT 2–3 cohort
a Waist circumference ≥ 94 cm for men; ≥ 80 for women
b Systolic blood pressure > 130 mmHg or diastolic > 85 mmHg
c Less than 150 min of moderate or 60 min of vigorous physical activity per week
Women (n = 20,014) Men (n = 16,147) All (N = 36,161)
Demographic factors
 Age (mean, SD) 46.8 (13.7) 47.3 (13.1) 47.0 (13.4)
 20–34 22.1% 19.5% 20.9%
 35–44 24.3% 24.2% 24.3%
 45–54 26.7% 27.9% 26.7%
 55–64 17.0% 17.7% 17.0%
 ≥ 65 11.5% 10.6% 11.1%
 Education (any post-secondary) 33.2% 30.1% 31.8%
Metabolic factors
 Central  obesitya 47.9% 36.9% 42.9%
 Hypertensionb 46.2% 66.5% 55.3%
 Triglycerides (high) 28.5% 48.5% 37.4%
 HDL cholesterol (low) 24.9% 29.1% 26.8%
 Plasma glucose (high) 2.1% 3.3% 2.6%
 Metabolic syndrome present 20.2% 23.1% 21.5%
Behavioural factors
 Smoking (packyears, mean) 12.8 (10.2) 17.2 (13.6) 14.9 (12.1)
 Former smoking (daily) 24.2% 33.5% 28.4%
 Current smoking (daily) 27.9% 24.5% 26.4%
 Physical  inactivityc 54.3% 48.2% 51.5%
Psychological factors
 Depression only 1.9% 1.3% 1.6%
 Anxiety only 5.3% 4.5% 4.9%
 Concurrent dep–anx 2.6% 1.9% 2.3%
 All (dep or anx) 9.8% 7.7% 8.8%
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depression risk independently, both of which could over-
estimate the independent PAF associated with depres-
sion when compared to our calculations. Our findings 
suggest that the joint effect of these factors may be more 
relevant to diabetes onset than their independent effects, 
and underscore the potential influence of psychologi-
cal factors on both metabolic and behavioural processes. 
While many relevant mediating relationships have been 
documented with respect to depression [4–6], symptoms 
of anxiety appeared to have a larger impact on these rela-
tionships in our study than depression (primarily due to 
the higher prevalence of anxiety in the population). Fur-
ther studies in this area should examine interactions with 
traditional risk factors when attempting to model diabe-
tes risk associated with depression or anxiety, as this may 
provide a truer depiction of psychological risk than is 
available in the literature to date.
With respect to the metabolic syndrome, a combined 
fraction of 49.1% of new diabetes cases was observed 
across all strata containing this factor. This is in line 
with previous research demonstrating a metabolic 
syndrome PAF of 30–52% for diabetes across multiple 
studies [19]. The independent effect of the metabolic 
syndrome alone conferred a higher proportion of cases 
in women (9.8%) than men (6.7%). This is somewhat 
unexpected given that men had higher frequencies of 
all metabolic risk factors at baseline, with the excep-
tion of central obesity, and may point to the increased 
tendency of men with the metabolic syndrome to 
experience behavioural and psychological comorbidi-
ties than women. This finding may be partly explained 
by the higher prevalence of central obesity in women 
(47.9% versus 36.9% in men), and is in line with pre-
vious research demonstrating that central obesity is a 
stronger predictor of metabolic syndrome status in 
women than men [38]. These findings suggest that 
women who do not have any concurrent behavioural or 
psychological risk may still be particularly vulnerable 
to the negative consequences of metabolic risk factors 
such as central obesity.
Table 2 Multivariate relative risk of incident Type 2 diabetes in HUNT 2–3 cohort, by sex
a Waist circumference ≥ 94 cm for men; ≥ 80 for women
b Systolic blood pressure > 130 mmHg or diastolic > 85 mmHg
c Less than 150 min of moderate or 60 min of vigorous physical activity per week
Women (n = 20,014) Men (n = 16,147) All (n = 36,161)
RR 95% CI RR 95% CI RR 95% CI
Demographic factors
 Age
  20–34 Ref Ref Ref Ref Ref Ref
  35–44 2.42 1.57, 3.74 2.97 1.90, 4.63 2.68 1.97, 3.65
  45–54 3.53 2.33, 5.36 4.45 2.90, 6.83 3.82 2.84, 5.14
  55–64 4.23 2.76, 6.48 5.68 3.68, 8.77 4.72 3.50, 6.37
  ≥ 65 2.97 1.88, 4.70 5.41 3.43, 8.52 3.88 2.83, 5.32
  Education (any post-secondary) 1.20 0.96, 1.50 1.19 1.00, 1.44 1.20 1.04, 1.38
Metabolic factors
 Central  obesitya 4.77 3.64, 6.25 3.31 2.75, 3.99 3.59 3.08, 4.18
 Hypertensionb 1.67 1.37, 2.04 1.49 1.22, 1.81 1.54 1.34, 1.77
 Triglycerides 1.98 1.63, 2.41 1.79 1.47, 2.19 1.77 1.55, 2.03
 HDL cholesterol 2.13 1.78, 2.54 1.84 1.57, 2.16 1.86 1.66, 2.10
 Plasma glucose 3.68 2.40, 4.03 5.58 3.31, 6.90 4.05 3.55, 4.62
Behavioural factors
 Smoking
  Never Ref Ref Ref Ref Ref Ref
  Former (daily) 0.87 0.71, 1.07 1.43 1.18, 1.72 1.13 0.99, 1.29
  Current (daily) 0.99 0.82, 1.22 1.50 1.22, 1.85 1.21 1.05, 1.39
  Physical  inactivityc 1.05 0.88, 1.24 1.38 1.18, 1.61 1.23 1.08, 1.36
Psychological factors
 Depression only 1.14 0.63, 2.08 1.94 1.34, 2.83 1.37 1.01, 1.87
 Anxiety only 1.24 0.92, 1.68 1.16 0.62, 2.16 1.16 0.76, 1.80
 Concurrent Dep–anx 0.93 0.56, 1.55 1.50 1.13, 2.00 1.36 1.10, 1.68
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Conversely, smoking and physical inactivity alone did 
not independently confer diabetes risk in women in our 
study, yet accounted for 8.9% of incident cases in men. 
In conjunction with depression or anxiety, these factors 
were associated with another 15.0% of incident cases 
in men. One partial explanation for this sex-related 
difference may be the higher prevalence of former smok-
ing reported by men, as well as the total number of pack-
years. The relationship between smoking and diabetes 
incidence is particularly pernicious in men, with research 
reflecting that men require double the length of time fol-
lowing smoking cessation to return to non-smoking dia-
betes risk levels (≥ 10  years, as opposed to ≥ 5  years in 
women) [39].
As illustrated in Fig.  3, the interaction of metabolic, 
behavioural, and psychological factors had a more pro-
found impact on diabetes incidence in men than women. 
The relative risk was 12.5 times higher in men experienc-
ing all four factors, accounting for 8.4% of new diabetes 
cases. By comparison, this risk was one third the size in 
women and accounted for only 4.0% of new cases. Pre-
vious research has demonstrated stronger effects of 
depression on glycemic control in men only [40], as well 
as the presence of elevated inflammation in men but not 
women with anxiety disorders [41]. Recent research also 
demonstrates higher mortality rates in men with Type 2 
diabetes experiencing concurrent depression and anxiety 
than women [42]. It may be possible that men experienc-
ing all four equivalent risk factors are more suscepti-
ble to their effects than women, or alternately that men 
reporting depression and anxiety at baseline tend to have 





















Depression X X X X
Anxiety X X X X
Dep-Anx X X X X
Behavioural
Factors X X X X X X X X
Metabolic 
Syndrome X X X X X X X X
Fig. 2 Attributable fractions for Type 2 diabetes onset in Norwegian 
adults associated with multiple risk factors (N = 36,161)
Table 3 Multivariate relative risks and  population attributable fractions (PAF) for Type 2 diabetes onset in  Norwegian 
adults associated with metabolic, behavioural and psychological risk factors (N = 36,161)
Adjusted for age and sex
a Physical inactivity and smoking factors
b Metabolic syndrome (as defined by the International Diabetes Federation [28])
Behaviourala MetSynb Depression Anxiety Concurrent 
dep–anx
# exposed Exposure 
prevalence 
(%)
Diabetes cases RR (95% CI) PAF
0 0 0 0 0 7602 21.02 123 1.00
0 0 1 0 0 803 2.22 10 0.93 (0.49, 1.76) –
0 0 0 1 0 1461 4.04 13 0.56 (0.32, 0.98) –
0 0 0 0 1 1319 3.65 25 1.31 (0.85, 2.00) –
1 0 0 0 0 11,309 31.27 218 1.13 (0.91, 1.41) –
1 0 1 0 0 1256 3.47 24 1.30 (0.85, 2.00) –
1 0 0 1 0 2447 6.77 52 1.26 (0.91, 1.73) –
1 0 0 0 1 2435 6.73 56 1.49 (1.09, 2.04) 1.4
0 1 0 0 0 1561 4.32 145 4.42 (3.49, 5.60) 8.4
0 1 1 0 0 135 0.37 15 6.87 (4.16, 11.35) 1.0
0 1 0 1 0 278 0.77 30 4.88 (3.17, 7.53) 1.8
0 1 0 0 1 255 0.71 22 5.46 (3.74, 7.97) 1.4
1 1 0 0 0 3493 9.66 376 5.26 (4.30, 6.42) 22.9
1 1 1 0 0 342 0.95 39 6.13 (4.36, 8.62) 2.5
1 1 0 1 0 766 2.12 81 5.29 (4.03, 6.93) 4.9
1 1 0 0 1 699 1.93 95 7.47 (5.79, 9.64) 6.2
Total 36,161 100 1324 50.5
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women reporting these symptoms within the same strata. 
Future research should attempt to unpack these interac-
tions within this high-risk group.
Strengths and limitations
This study used a large population-based sample of Nor-
wegian adults, and allowed for an appropriate follow-up 
time to assess diabetes incidence. We rigorously con-
trolled for a range of clinical and sociodemographic 
covariates and exposures. We also used a formula for 
calculating population attributable risk that was valid in 
the presence of confounding and interaction, and pro-
vided an intuitive presentation of these results. Instead 
of focusing on the potential proportion of diabetes cases 
that could be reduced by eliminating depression or anxi-
ety in the population overall, the current analysis allows 
an examination of strata in which targeted treatment of 
these symptoms might be more beneficial. For example, 
of our study population who experienced symptoms of 
depression and anxiety at baseline, only 13.6% of these 
individuals developed diabetes during follow-up, yet they 
accounted for 19.2% of new cases. Given these findings 
and the current diabetes epidemic, research to deter-
mine whether treating anxiety and depression in peo-
ple exposed to other diabetes risk factors is effective in 
reducing the incidence rate may therefore prove to be 
useful [43].
However, we are unable to assume a direct causal link 
between depression and anxiety and diabetes incidence. 
As noted by Flegal et al. direct causal assumptions are not 
necessarily warranted when using PAFs [44]—as a result 
of mediational processes, different methods of interven-
ing on a modifiable factor such as obesity may lead to 
different counterfactual outcomes, even if they achieve 
identical reductions in weight [45]. We were also unable 
to calculate partial or summary attributable risks as not 
all relative risks were greater than 1, and were therefore 
unable to report the summed contributions of each indi-
vidual risk factor (i.e., ‘column totals’). This highlighted 
the importance of the interaction between psychological 
factors and metabolic and behavioural factors in eliciting 
effects on diabetes onset.
In addition, as risk factors were measured simultane-
ously at baseline, it was not possible to assess mediat-
ing relationships or to differentiate between distal and 
proximal mechanisms of risk underlying these associa-
tions. Although the diabetes risk related to behavioural 
factors was relatively low in this study, these factors tend 
to confer disease risk through their subsequent effects on 
metabolic processes. For example, physical inactivity or 
smoking in individuals prior to baseline may have precip-
itated changes in metabolic health which persisted even 
if their behavioural risk status had changed by the time 
of assessment. It is therefore likely that we have underes-
timated the true impact of behavioural factors in the pre-
sent study. Previous research on non-participation in the 
HUNT 3 study has also demonstrated that both mental 
health and diabetes status are linked to study non-par-
ticipation [46], and it is therefore possible that this study 
underestimated the true incidence rate of diabetes in the 
Norwegian population. As with all observational studies, 
our results are also vulnerable to the presence of unmeas-
ured confounding.
It is worth noting that PAFs are highly influenced by 
the population prevalence of the risk factor of interest. 
In the aforementioned study of sugar sweetened bever-
ages, the authors reported that while the PAF for diabetes 
cases in the USA was 8.7%, it was only 3.6% in the UK. 
These values may therefore vary in countries outside of 
Norway, where the prevalence of diabetes risk factors dif-
fers. Future research should quantify these effects within 
each target population of interest prior to using them to 
inform local health strategies.
In addition, it is worth noting that not all individuals 
exposed to the same complement of risk factors will dis-
play the same diabetes phenotype. Many genetic factors, 
gene–gene and gene-environment interactions can affect 
the onset and type of diabetes mellitus. We did not have 
access to genetic data for this study, and the addition of 
this data could prompt an interesting extension of the 
current research.
Conclusions
Overall, the presence of the metabolic syndrome in 
conjunction with behavioural factors was the larg-



















Depression X X X X
Anxiety X X X X
Dep-Anx X X X X
Behavioural
Factors X X X X X X X X
Metabolic 
Syndrome X X X X X X X X
Fig. 3 Relative Risk for Type 2 diabetes onset in Norwegian adults 
associated with multiple risk factors, by sex (N = 36,161)
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population. In addition, symptoms of depression and 
anxiety increased the percentage of excess diabetes cases 
attributable to common behavioural and metabolic fac-
tors, particularly in men. This study highlights the impor-
tance of risk factor clustering in diabetes onset, and is the 
first that we know of to quantify the excess fraction of 
incident diabetes associated with psychological risk fac-
tor interactions.
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